Volume 13, Number 4, 565-571, DOI: 10.1245/ASO.2006.12.024

Published in partnership with

Logo

SSO and ASBS

Recurrence After Cystectomy for Borderline Ovarian Tumors: Results of a French Multicenter Study

Christophe Poncelet, Raffaèle Fauvet, Joëlle Boccara and Emile Daraï

View Related Documents

Abstract

Background  

Fertility-sparing surgery for borderline ovarian tumors (BOT) is feasible and effective and does not seem to have a negative effect on survival. Specific data on the effect of cystectomy, and notably on recurrence, are lacking.

Methods  

This was a French retrospective multicenter study of 313 women with stage I BOT treated from 1990 to 2000 in 13 specialized gynecological units and 1 cancer center. Diagnosis and staging were based on International Federation of Gynecology and Obstetrics (1989) criteria. Surgery consisted of cystectomy, unilateral salpingo-oophorectomy (USO), or bilateral salpingo-oophorectomy (BSO).

Results  

After cystectomy, persistent BOT and benign ovarian cysts on the operated ovary were observed in 15% and 65% of patients, respectively. Mean follow-up did not differ among patients receiving the three types of surgery. The recurrences after cystectomy, USO, and BSO treatment were 30.3%, 11%, and 1.7%, respectively (P < .0001). Recurrences were more frequent after cystectomy than after USO (P = .0001) and BSO (P = .0001) and when intraoperative cyst rupture occurred (P = .04).

Conclusions  

These results suggest that cystectomy for BOT is associated with a high risk of intraoperative cyst rupture and of recurrence compared with USO or BSO.

Keywords  Borderline ovarian tumors - Recurrence - Cystectomy - Persistent tumor - Salpingo-oophorectomy

Fulltext Preview

Image of the first page of the fulltext document